Sugi Predict

Sugi Predict / Compounds / SCHEMBL4155602

SCHEMBL4155602

SCHEMBL4155602

CCNC(=O)c1ccc(OC)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 6/20 0.69
▸ RAB9A P51151 4/20 0.69
▸ KMT2A Q03164 2/20 0.69
▸ CA1 P00915 3/20 0.67
▸ CA2 P00918 3/20 0.67
▸ PKM P14618 1/20 0.65
▸ PLK1 P53350 1/20 0.63
▸ SMN1; SMN2 Q16637 2/20 0.62
▸ HPGD P15428 1/20 0.62
▸ HDAC3 O15379 2/20 0.59
▸ HDAC1 Q13547 2/20 0.59
▸ HDAC2 Q92769 2/20 0.59
▸ HDAC4 P56524 1/20 0.59
▸ HDAC7 Q8WUI4 1/20 0.59
▸ HDAC10 Q969S8 1/20 0.59
▸ HDAC11 Q96DB2 1/20 0.59
▸ HDAC8 Q9BY41 1/20 0.59
▸ HDAC6 Q9UBN7 1/20 0.59
▸ HDAC9 Q9UKV0 1/20 0.59
▸ HDAC5 Q9UQL6 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6309323 0.95 KMT2A (0.63) NPC1RAB9AKMT2ACA1CA2
SCHEMBL16685001 0.86 NPC1 (0.83) NPC1RAB9ACA1CA2PKM
SCHEMBL28196787 0.86 KMT2A (0.61) NPC1RAB9AKMT2ACA1CA2
SCHEMBL5909057 0.85 CA12 (0.58) NPC1RAB9AKMT2APLK1HPGD
SCHEMBL6360344 0.85 NPC1 (0.75) NPC1RAB9AKMT2ACA1CA2
SCHEMBL8598019 0.85 NPC1 (0.69) NPC1RAB9AKMT2ACA1CA2
SCHEMBL3914626 0.84 KMT2A (0.73) NPC1RAB9AKMT2ACA1CA2
SCHEMBL10294638 0.83 RAB9A (0.75) NPC1RAB9AKMT2APLK1SMN1; SMN2
SCHEMBL6546014 0.83 PKM (0.68) NPC1RAB9AKMT2ACA1CA2
SCHEMBL11370186 0.83 NPC1 (0.67) NPC1RAB9AKMT2ACA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9770446-B2 Piperidine urea derivatives MERCK PATENT GMBH (DE) 2017-09-26 — — US claimed
US-20160184285-A1 PIPERIDINE UREA DERIVATIVES MERCK PATENT GMBH (DE) 2016-06-30 — — US claimed
CN-115677696-A Preparation method of benzonaphthyridine derivative 华侨大学 2023-02-03 — — CN disclosed
CN-112299938-B Method for preparing amine compound by reducing amide compound 中国科学院兰州化学物理研究所 2021-12-28 — — CN disclosed
US-10966967-B2 Aryl dihydropyridinones and piperidinone MGAT2 inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2021-04-06 — — US disclosed
CN-104761420-B Method for synthesizing amide from methyl aromatic hydrocarbon and amine in water phase 江西师范大学 2021-03-05 — — CN disclosed
CN-112299938-A Method for preparing amine compound by reducing amide compound 中国科学院兰州化学物理研究所 2021-02-02 — — CN disclosed
US-20200281905-A1 ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2020-09-10 — — US disclosed
US-10369140-B2 Aryl dihydropyridinones and piperidinone MGAT2 inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2019-08-06 — — US disclosed
US-20180133198-A1 ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-05-17 — — US disclosed
US-9901572-B2 Aryl dihydropyridinones and piperidinone MGAT2 inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2018-02-27 — — US disclosed
US-4157441-A PROSTAGLANDINS, ANTIINFLAMMATORY AGENTS THE UPJOHN COMPANY (US) 1979-06-05 — — US disclosed
US-4151351-A PROSTAGLANDINS, ANTIINFLAMMATORY THE UPJOHN COMPANY (US) 1979-04-24 — — US disclosed
US-4131738-A 6-Hydroxy-PGE1 compounds THE UPJOHN COMPANY (US) 1978-12-26 — — US disclosed
US-4128713-A 6,7-Didehydro-PGI1 compounds THE UPJOHN COMPANY (US) 1978-12-05 — — US disclosed
US-4126744-A PROSTACYCLIN, MUSCLE STIMULANTS, PLATELET AGGREGATION INHIBITORS THE UPJOHN COMPANY (US) 1978-11-21 — — US disclosed
US-4112224-A PROSTAGLANDIN THE UPJOHN COMPANY (US) 1978-09-05 — — US disclosed
US-4109082-A PROSTACYCLIN ANALOGS; SMOOTH MUSCLE STIMULATORS THE UPJOHN COMPANY (US) 1978-08-22 — — US disclosed
US-4100192-A Inter-phenylene-PG amides THE UPJOHN COMPANY (US) 1978-07-11 — — US disclosed
US-4097489-A PROSTAGLANDINS THE UPJOHN COMPANY (US) 1978-06-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180133198-A1 ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS DGAT2, MGAT2, MGAT1 NPC1 97/4885RAB9A 1973/4885KMT2A 155/4885
US-10369140-B2 Aryl dihydropyridinones and piperidinone MGAT2 inhibitors DGAT2, MGAT2, MGAT1 NPC1 97/4885RAB9A 1973/4885KMT2A 155/4885
US-10966967-B2 Aryl dihydropyridinones and piperidinone MGAT2 inhibitors DGAT2, MGAT2, MGAT1 NPC1 97/4885RAB9A 1973/4885KMT2A 155/4885
US-20200281905-A1 ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS DGAT2, MGAT2, MGAT1 NPC1 97/4885RAB9A 1973/4885KMT2A 155/4885
US-20160184285-A1 PIPERIDINE UREA DERIVATIVES PRMT1, TNKS, PRMT3 NPC1 3643/4885RAB9A 2999/4885KMT2A 1237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.